Latest Breaking News On - Sorraya popal - Page 1 : comparemela.com

/PRNewswire/ Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug.

Noord hollandInnovent biologicsJorin hoogenboomSander van berkelSynaffix hydraspaceRemon van geelMarloes wijdevenExatecan syntecanSorraya popalJord van schaikPlatform technologyShow excellent in vivo efficacyLaureen de beverKyowa kirinMersana therapeuticsShanghai miracogen